Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients

NCT07229170 · Recruiting

Last updated 2026-05-28

This clinical trial examines how GLP-1 agonists affect taste and eating habits in adults with obesity or overweight who are trying to lose weight.

Status Recruiting Currently enrolling participants.

Type Observational

Participants 150 people Planned (estimated).

Who can join Ages 18–60 · all sexes

Timeline Started 2025-12 · est. completion 2028-01

Where 4 sites · Italy

What this study is testing ClinicalTrials.gov NCT07229170 ↗

Description as written by the study sponsor.

This observational retrospective study aims to evaluate changes in taste perception, eating habits, and behavioral aspects in adults treated with GLP-1 receptor agonists for weight loss. Participants include adults aged 18-60 receiving treatment at specialized nutrition centers in Italy. Data are collected from clinical records, dietary questionnaires, and metabolic assessments before and after at least 12 weeks of GLP-1 agonist treatment. The study's primary goal is to understand how these treatments affect food preferences and taste perception. Secondary outcomes include changes in body weight, body composition, gastrointestinal side effects, and treatment adherence. All data are anonymized and collected according to ethical guidelines.

Main thing measured	Change in taste perception and food preferences
Sponsor	San Raffaele Telematic University
Conditions studied	Obesity & Overweight, Taste Alterations, Weight Loss, Eating Behavior Changes
GLP-1 drugs	—

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT07229170 ↗